secwatch.observer — SEC 8-K summary
======================================

Issuer:     Serina Therapeutics, Inc. (SER)
CIK:        0001708599
Form:       8-K
Filed at:   2024-05-03T23:59:59+00:00
Accession:  0001493152-24-017731
Event type: other
Sentiment:  neutral
Materiality: 0.50
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Serina Therapeutics replaces Withum with Frazier & Deeter as auditor after merger
--------------------------------------------------------------------------------

- Audit committee approved Frazier & Deeter as independent auditor for FY2024, replacing Withum.
- Withum's reports for FY2022 and FY2023 had no adverse opinion except going concern doubt.
- No disagreements with Withum on accounting principles or audit scope during those periods.
- Withum provided a letter (Exhibit 16.1) agreeing with the disclosures in this filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1708599/000149315224017731/0001493152-24-017731-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1708599/000149315224017731/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-017731

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer